BGLC news

BioNexus Gene Lab agreed to license CogniAI technology from Ruanyun Edai in exchange for shares and future investments expanding into Southeast Asia, marking a significant corporate expansion.

BioNexus announced continued progress in commercializing the VitaGuard platform in Southeast Asia following a working visit to Tongshu Gene sites in China led by Dr. Muthu Meyyappan. This development demonstrates tangible market relevance for BioNexus' direct path into precision oncology through its…

BioNexus Gene Lab Corp CEO Sam Tan spoke at a China-Malaysia Economic Cooperation Forum advocating for deeper biotech co-development partnerships between the countries. The company highlighted its Fidelion Diagnostics model as an example of structuring China-origin innovation with international comm…